<analysis>
**Action 1 (successor-training experiment).** This is internal work through existing channels with two named leads, so its execution risk is moderate.
- Renewal at about 9% is plausible, since December's results were real, if modest. Threat 3 separately models a cut, so I do not price it here.
- The hard parts inside four weeks are recruiting independent human evaluators and building hidden variants that look like production traffic. Successor handoffs also need a checkpoint cadence the team may not control.
- A preregistered "do not recommend" outcome still counts as a deliverable, which lowers the chance of outright failure.
- Contamination of the concealed variants is Threat 1, and I do not count it twice.

**Action 2 (agent package repair).** Building an external action broker, then replaying the workload and running an escape campaign, all by 14 January, is an aggressive schedule.
- Reaching 95% completion with under 10% added latency on the first iteration is unlikely. Security reviews and publication sign-off add delay.
- The escape risk is Threat 4 and the quiet-period freeze is Threat 2, so neither is priced here. What remains is the engineering schedule plus normal release friction.

**Action 3 (integration package, external reproduction).** Several parties must act in one month: publication review, an external lab or evaluator executing a reproduction, and the training owner agreeing to a documented accept/reject step.
- OpenAI and GDM contacts are busy with their own releases.
- Independent evaluators could plausibly reproduce a result, but not within weeks of receiving the package.
- The judge's standard applies: multi-party commitments inside one month should be priced at 70% failure or higher.

**Action 4 (policy campaign).** The new Congress convenes on 3 January, and committee assignments and staffing take weeks.
- The Grok 5 four-day CAISI window gives AI-sceptic members a hook, so staff-level interest is plausible.
- "Prospective champions" is a soft bar. A purchaser agreeing to test the clauses is slower, because procurement and legal review take quarters.
- Essay approval is gated by comms and the quiet period (Threat 2).

**Action 5 (worker gainsharing contract).** One month is not enough to negotiate a funded 500-worker gainsharing agreement with worker representatives and an employer. Enterprise procurement plus labour negotiation typically takes quarters. The nonprofit sub-work will likely happen, but the headline target will likely not.

**Action 6 (science pipeline).** Funding is small, but pre-IPO finance slowed it in December. Getting the cell-stage experiment actually underway in January requires both funding and lab scheduling. Alt-protein producers are cash-constrained, though a fixed-cost test on existing equipment is cheap. The action needs either leg to succeed to count as a partial success.

**Threats**
- **Threat 1:** Highly plausible, given December's probe results and a more capable successor model.
- **Threat 2:** Depends on the filing status, which remains unconfirmed.
- **Threat 3:** A compound event. GPT-6 must ship in January, with short testing, and Anthropic must respond with an allocation cut.
- **Threat 4:** Standard red-team outcomes usually find something.
- **Threat 5:** A DeepSeek release within the month, plus an attributed incident, is the less likely combination.
</analysis>

<action_odds>
Action 1 [Alignment engine → successor experiment]: P(failure) 35%. Reason: existing channel and leads, and a negative result is an acceptable deliverable. Risk comes from evaluator recruitment and building concealed variants and handoffs in four weeks. Contamination and compute-cut risks are priced in Threats 1 and 3.

Action 2 [Agent package repair and release]: P(failure) 55%. Reason: building the broker and running the escape campaign in two weeks is tight. The completion and latency targets are unlikely on the first pass, and release review adds friction. Escape and quiet-period risks are left to Threats 4 and 2.

Action 3 [Integration package and external reproduction]: P(failure) 72%. Reason: needs several parties in one month (publication review, an external reproduction, the training owner's decision process). Competitor labs are preoccupied with their own launches.

Action 4 [Policy campaign and procurement clauses]: P(failure) 72%. Reason: a new Congress in its organising month and procurement legal cycles. The Grok 4-day-window hook helps with staff interest but not with commitments.

Action 5 [Worker gainsharing contract]: P(failure) 82%. Reason: a negotiated 500-worker funded agreement with worker representatives in one month is far outside the base rate. Only the nonprofit sub-work is likely.

Action 6 [Fibrosis experiment and alt-protein test]: P(failure) 55%. Reason: small, bounded asks, but pre-IPO finance delayed the funding in December. Lab scheduling limits "underway" status, and producers have cash constraints.
</action_odds>

<threat_odds>
Threat 1 [Successor detects disguised tests]: P(materialises) 42%. Adversary suggested 40%; this is roughly the same. December's probe finding and a more capable successor make it likely, and synthetic data is hard to disguise, but the team is now designing specifically against this.

Threat 2 [IPO quiet period freezes publication]: P(materialises) 38%. Adversary suggested 45%. The filing status is unconfirmed, and ordinary-course research publication often continues during quiet periods. The attributed policy essay is the most exposed item.

Threat 3 [GPT-6 lands and alignment compute is cut]: P(materialises) 22%. Adversary suggested about 22% compound; this matches. January releases often slip, and even a short-window launch does not guarantee a cut. December's precedent keeps the probability non-trivial.

Threat 4 [Escape via allowlisted domain]: P(materialises) 38%. Adversary suggested 35%; slightly higher. Adversarial campaigns against allowlisted package and artifact services commonly find exfiltration channels, and December already showed this class of flaw.

Threat 5 [DeepSeek release narrows cyber gap]: P(materialises) 25%. Adversary suggested 35% for the release. A January release is plausible but not signalled for a specific date, and a widely attributed incident in the same month is less likely. If the threat materialises, it mainly means the release; the incident is a secondary element.
</threat_odds>
